Clinical trial
SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for…
NCT00114972 · Boston Scientific Corporation, Industry · Unknown status
Key facts
| NCT number | NCT00114972 |
|---|---|
| Title | SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries |
| Official title | SYNTAX Study: SYNergy Between PCI With TAXUS and Cardiac Surgery |
| Acronym | SYNTAX |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Collaborators | Cardialysis BV Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device, Procedure |
| Interventions | Polymer-based Paclitaxel-Eluting TAXUS Express2-SR Stent, Coronary Artery Bypass Surgery |
| Enrollment | 1,800 |
| Start date | Mar 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | May 1, 2012 |
| First posted | Jun 21, 2005 |
| Last update posted | Jun 23, 2010 |
| Countries | Austria, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Latvia, Netherlands, Norway and 6 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: